Brief: Heidelberg Pharma Q1 Net Loss Widens To EUR 4.6 Million

Heidelberg Pharma AG

23/04/2020 06:15

April 23 (Reuters) - HEIDELBERG PHARMA AG  WL6G.DE :
    * INTERIM MANAGEMENT STATEMENT ON THE FIRST THREE MONTHS OF
2020
    * CONFIRMS ITS FULL-YEAR FINANCIAL GUIDANCE ISSUED ON 19
MARCH
2020
    * NET LOSS FOR FIRST THREE MONTHS OF FISCAL YEAR INCREASED
TO EUR
4.6 MILLION, AS PLANNED (PREVIOUS YEAR: EUR 3.1 MILLION)
    * Q1 SALES REVENUE AND INCOME TOTALING EUR 1.8 MILLION
(PREVIOUS
YEAR: EUR 1.3 MILLION)
    * COMPANY'S FINANCING IS SECURED UNTIL MID-2021

Source text for Eikon:  ID:nEQ9csPTwa 
Further company coverage:  WL6G.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))